4/18
09:28 am
sttk
Owning 36% shares,institutional owners seem interested in Shattuck Labs, Inc. (NASDAQ:STTK), [Yahoo! Finance]
Low
Report
Owning 36% shares,institutional owners seem interested in Shattuck Labs, Inc. (NASDAQ:STTK), [Yahoo! Finance]
4/9
04:15 pm
sttk
Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024 [Yahoo! Finance]
Medium
Report
Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024 [Yahoo! Finance]
4/9
04:05 pm
sttk
Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024
Medium
Report
Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024
4/9
08:09 am
sttk
Shattuck Labs, Inc. (NASDAQ: STTK) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock.
Medium
Report
Shattuck Labs, Inc. (NASDAQ: STTK) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock.
4/1
07:00 am
sttk
Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare Conference
Low
Report
Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare Conference
3/5
01:52 pm
sttk
Shattuck Labs Full Year 2023 Earnings: Beats Expectations [Yahoo! Finance]
Low
Report
Shattuck Labs Full Year 2023 Earnings: Beats Expectations [Yahoo! Finance]
3/4
07:17 am
sttk
Shattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D., to its Board of Directors [Yahoo! Finance]
Medium
Report
Shattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D., to its Board of Directors [Yahoo! Finance]
3/4
07:00 am
sttk
Shattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D., to its Board of Directors
Medium
Report
Shattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D., to its Board of Directors
3/1
08:14 am
sttk
Shattuck Labs, Inc. (NASDAQ: STTK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $28.00 price target on the stock.
Medium
Report
Shattuck Labs, Inc. (NASDAQ: STTK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $28.00 price target on the stock.
3/1
08:13 am
sttk
Shattuck Labs, Inc. (NASDAQ: STTK) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock.
Medium
Report
Shattuck Labs, Inc. (NASDAQ: STTK) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock.
2/29
04:26 pm
sttk
Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights [Yahoo! Finance]
High
Report
Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights [Yahoo! Finance]
2/29
04:05 pm
sttk
Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights
High
Report
Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights
2/26
07:00 am
sttk
Shattuck Labs Announces Participation in Upcoming March Conferences
High
Report
Shattuck Labs Announces Participation in Upcoming March Conferences
2/14
05:11 am
sttk
Ono Enters into a Drug Discovery Collaboration and Option Agreement with Shattuck Labs to Generate Bifunctional Fusion Proteins [Yahoo! Finance]
Low
Report
Ono Enters into a Drug Discovery Collaboration and Option Agreement with Shattuck Labs to Generate Bifunctional Fusion Proteins [Yahoo! Finance]
2/14
05:06 am
sttk
Ono Enters into a Drug Discovery Collaboration and Option Agreement with Shattuck Labs to Generate Bifunctional Fusion Proteins
Low
Report
Ono Enters into a Drug Discovery Collaboration and Option Agreement with Shattuck Labs to Generate Bifunctional Fusion Proteins
2/14
12:25 am
sttk
Two Biotech/pharma stocks to watch - STTK, KALV [Seeking Alpha]
Neutral
Report
Two Biotech/pharma stocks to watch - STTK, KALV [Seeking Alpha]
2/13
01:18 pm
sttk
Shattuck Labs, Inc. (NASDAQ: STTK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $28.00 price target on the stock.
Low
Report
Shattuck Labs, Inc. (NASDAQ: STTK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $28.00 price target on the stock.
2/13
10:21 am
sttk
Shattuck Labs, Inc. (NASDAQ: STTK) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock.
Medium
Report
Shattuck Labs, Inc. (NASDAQ: STTK) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock.
2/13
06:06 am
sttk
Shattuck Labs Enters into Strategic Collaboration and License Agreement with Ono Pharmaceutical to Generate Bifunctional Fusion Proteins for the Treatment of Autoimmune and Inflammatory Diseases [Yahoo! Finance]
High
Report
Shattuck Labs Enters into Strategic Collaboration and License Agreement with Ono Pharmaceutical to Generate Bifunctional Fusion Proteins for the Treatment of Autoimmune and Inflammatory Diseases [Yahoo! Finance]
2/13
06:00 am
sttk
Shattuck Labs Enters into Strategic Collaboration and License Agreement with Ono Pharmaceutical to Generate Bifunctional Fusion Proteins for the Treatment of Autoimmune and Inflammatory Diseases
Medium
Report
Shattuck Labs Enters into Strategic Collaboration and License Agreement with Ono Pharmaceutical to Generate Bifunctional Fusion Proteins for the Treatment of Autoimmune and Inflammatory Diseases